Vir Biotechnology Inc.

NAS: VIR

GO
/marketstate/country/us

Market open

VIR
/zigman2/quotes/214486077/composite

$

46.20

Change

-1.22 -2.57%

Volume

Volume 1.30m

Dec 1, 2021, 11:27 a.m.

Real time quotes

/zigman2/quotes/214486077/composite

Previous close

$ 47.42

$ 46.20

Change

-1.22 -2.57%

Day low

Day high

$41.10

$46.98

Open
Open: 43.81

52 week low

52 week high

$25.31

$141.01

Open

Market cap

$6.21B

Average volume

1.18M

P/E ratio

N/A

Rev. per Employee

$233,541

EPS

-0.87

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vir

MarketWatch News on VIR

  1. FDA advisers recommend Merck’s COVID-19 pill in close vote

    7:53 a.m. Today

    - Jaimy Lee

  2. Stock Market Jitters Continue Over Covid. It's Too Early to Panic.

    9:57 a.m. Nov. 30, 2021

    - Josh Nathan-Kazis

  3. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Josh Nathan-Kazis

  4. Glaxo and Vir COVID-19 treatment meets endpoint in Phase III trial

    7:21 a.m. Nov. 12, 2021

    - Steve Goldstein

  5. Pfizer's Covid Antiviral Shows Stunning Efficacy

    9:19 a.m. Nov. 5, 2021

    - Josh Nathan-Kazis

  6. Vir Biotechnology upgraded to neutral from underweight at J.P. Morgan

    6:54 a.m. Oct. 25, 2021

    - Tomi Kilgore

  7. Don't Count Out Covid-19 Monoclonal Antibody Treatments

    11:04 a.m. Oct. 15, 2021

    - Josh Nathan-Kazis

  8. FDA Will Consider Regeneron's Covid-19 Antibody for Full Approval

    10:39 a.m. Oct. 14, 2021

    - Josh Nathan-Kazis

  9. Merck Submits Covid Pill to FDA for Emergency Approval

    8:27 a.m. Oct. 11, 2021

    - Jack Denton

  10. Merck’s Covid Pill Could Pose Serious Risks, Scientists Warn

    6:47 a.m. Oct. 8, 2021

    - Josh Nathan-Kazis

  11. Loading more headlines...
/news/nonmarketwatch/company/us/vir

Other News on VIR

  1. MCRB, DADA and ATXI among mid-day movers

    1:18 p.m. Nov. 30, 2021

    - Seeking Alpha

  2. Why Vir Biotechnology Stock Is Soaring Today

    11:32 a.m. Nov. 30, 2021

    - Motley Fool

  3. VIR, HEPA and POLA among pre market gainers

    8:28 a.m. Nov. 30, 2021

    - Seeking Alpha

  4. Covid Antibody Drugs Challenged by Omicron

    6:00 a.m. Nov. 30, 2021

    - Joseph Walker

  5. Why Vir Biotechnology Is Up More Than 13% Today

    12:29 p.m. Nov. 29, 2021

    - Motley Fool

  6. Company News for Nov 29, 2021

    8:36 a.m. Nov. 29, 2021

    - Zacks.com

  7. Merck’s Covid-19 Pill Was 30% Effective in Final Analysis

    1:14 p.m. Nov. 26, 2021

    - Jared S. Hopkins

  8. TDOC, VXRT and CDOX among pre market gainers

    8:25 a.m. Nov. 26, 2021

    - Seeking Alpha

  9. COVID-19 vaccine stocks surge on worries over new variant

    6:58 a.m. Nov. 26, 2021

    - Seeking Alpha

  10. Pfizer (PFE) Inks $5.3B COVID Pill Supply Deal With U.S.

    9:32 a.m. Nov. 19, 2021

    - Zacks.com

  11. GOEV, XERS and CEI among pre market gainers

    8:33 a.m. Nov. 17, 2021

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/vir

Press Releases on VIR

  1. 4 Top Biotech Stocks To Watch Now

    5:07 p.m. Nov. 29, 2021

    - StockMarket.com

  2. Section 32 Raises $740 Million Venture Fund

    7:14 a.m. Nov. 4, 2021

    - PR Newswire - PRF

  3. Friday Sector Laggards: Biotechnology, Diagnostics

    12:39 p.m. Oct. 1, 2021

    - MarketNewsVideo.com

  4. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.